Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance
Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance
复制标题
DOI：
10.1002/cac2.12518
复制
发表时间：
2023
影响因子：
16.2
通讯作者：
Shan-Chao Zhao
中科院分区：
文献类型：
--
作者：
Chen Ming‐Kun;Chen Zi‐Xian;Cai Mao‐Ping;Chen Hong;Chen Zhuang‐Fei;Shan-Chao Zhao
AbstractTargeted delivery of anti‐tumor drugs and overcoming drug resistance in malignant tumor cells remain significant clinical challenges. However, there are only few effective methods to address these issues. Extracellular vesicles (EVs), actively secreted by cells, play a crucial role in intercellular information transmission and cargo transportation. Recent studies have demonstrated that engineered EVs can serve as drug delivery carriers and showed promising application prospects. Nevertheless, there is an urgent need for further improvements in the isolation and purification of EVs, surface modification techniques, drug assembly processes, and precise recognition of tumor cells for targeted drug delivery purposes. In this review, we summarize the applications of engineered EVs in cancer treatment and overcoming drug resistance, and current challenges associated with engineered EVs are also discussed. This review aims to provide new insights and potential directions for utilizing engineered EVs as targeted delivery systems for anti‐tumor drugs and overcoming drug resistance in the near future.
